Prot # GS-US-330-0101: A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of GS-4774 for the Treatment of Virally-Suppressed Subjects with Chronic Hepatitis B

Project: Research project

Project Details

StatusFinished
Effective start/end date11/5/1311/5/16

Funding

  • PRA Health Sciences (GS-US-330-0101)
  • Gilead Sciences, Inc. (GS-US-330-0101)